Summary of key recommendations

Revision as of 17:30, 27 October 2016 by Sara Mehrsefat (talk | contribs) (Created page with "__NOTOC__ {{Hypercholesterolemia}} {{CMG}} ==Summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults== {|class="wikitable" style=...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults

Class I
"1. RECOMMENDATION 1 HERE(Level of Evidence: A)"
"2. RECOMMENDATION 2 HERE(Level of Evidence: B)"
Class III (Harm)
"1. RECOMMENDATION 1 HERE (Level of Evidence: C)"
"2. RECOMMENDATION 2 HERE (Level of Evidence: C)"
Class III (No Benefit)
"1. RECOMMENDATION 1 HERE (Level of Evidence: C)"
"2. RECOMMENDATION 2 HERE (Level of Evidence: C)"
Class IIa
"1. RECOMMENDATION 1 HERE (Level of Evidence: C)"
"2. RECOMMENDATION 2 HERE (Level of Evidence: C)"
Class IIb
"1. RECOMMENDATION 1 HERE (Level of Evidence: C)"
"2. RECOMMENDATION 2 HERE (Level of Evidence: C)"